170 related articles for article (PubMed ID: 6146498)
1. Bronchodilator therapy in chronic airflow obstruction.
Niewoehner DE; Leatherman JW
Chest; 1984 Aug; 86(2):161-2. PubMed ID: 6146498
[No Abstract] [Full Text] [Related]
2. Therapeutic implications of a precise diagnosis of airflow obstruction.
Picado C
Eur Respir J; 1990 Oct; 3(9):1091-4. PubMed ID: 1981193
[No Abstract] [Full Text] [Related]
3. [Bronchodilatation and anticholinergic agents].
Tschopp JM
Schweiz Rundsch Med Prax; 1990 May; 79(22):698-9. PubMed ID: 1971962
[TBL] [Abstract][Full Text] [Related]
4. Choosing a drug regimen for obstructive pulmonary disease. 1. Agents to achieve bronchodilatation.
Plummer AL
Postgrad Med; 1978 Apr; 63(4):36-41, 44-6, 48. PubMed ID: 24835
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study.
Tashkin DP; Ashutosh K; Bleecker ER; Britt EJ; Cugell DW; Cummiskey JM; DeLorenzo L; Gilman MJ; Gross GN; Gross NJ
Am J Med; 1986 Nov; 81(5A):81-90. PubMed ID: 2947465
[TBL] [Abstract][Full Text] [Related]
6. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.
Chapman KR; Wanner A
Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777
[No Abstract] [Full Text] [Related]
7. Results of a multicenter study of nebulized inhalant bronchodilator solutions.
Tashkin DP; Bleecker E; Braun S; Campbell S; DeGraff AC; Hudgel DW; Boyars MC; Sahn S
Am J Med; 1996 Jan; 100(1A):62S-69. PubMed ID: 8610720
[TBL] [Abstract][Full Text] [Related]
8. Bronchodilator responses to anticholinergic and beta-adrenergic agents in acute and stable COPD.
Karpel JP
Chest; 1991 Apr; 99(4):871-6. PubMed ID: 1672634
[TBL] [Abstract][Full Text] [Related]
9. Drug strategies for airflow obstruction.
Petty TL
Am J Nurs; 1987 Feb; 87(2):180-4. PubMed ID: 2880508
[No Abstract] [Full Text] [Related]
10. Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.
Cazzola M; Donner CF; Matera MG
Thorax; 1999 Aug; 54(8):730-6. PubMed ID: 10413727
[No Abstract] [Full Text] [Related]
11. [Bronchodilator treatment of chronic obstructive bronchopneumopathies].
Meslier N; Racineux JL
Rev Mal Respir; 1993; 10(2):79-85. PubMed ID: 8099224
[No Abstract] [Full Text] [Related]
12. Bronchodilator therapy of COPD. A reanalysis suggests new roles and new concerns.
Deffebach ME
Chest; 1996 Jul; 110(1):5-6. PubMed ID: 8681663
[No Abstract] [Full Text] [Related]
13. [Bronchodilator treatment of COPD].
Naberan K
Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
[No Abstract] [Full Text] [Related]
14. Bronchodilator therapy in obstructive lung disease.
McFadden ER
N Engl Reg Allergy Proc; 1985; 6(3):241-4. PubMed ID: 2888011
[TBL] [Abstract][Full Text] [Related]
15. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
Matera MG; Caputi M; Cazzola M
Respir Med; 1996 Sep; 90(8):497-9. PubMed ID: 8869445
[No Abstract] [Full Text] [Related]
16. Anticholinergic bronchodilators for adult obstructive airways disease.
Chapman KR
Am J Med; 1991 Oct; 91(4A):13S-16S. PubMed ID: 1835290
[TBL] [Abstract][Full Text] [Related]
17. Combination bronchodilator therapy in COPD.
Rennard SI
Chest; 1995 May; 107(5 Suppl):171S-175S. PubMed ID: 7743822
[No Abstract] [Full Text] [Related]
18. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD.
Ikeda A; Nishimura K; Izumi T
Chest; 1996 Jan; 109(1):294. PubMed ID: 8549208
[No Abstract] [Full Text] [Related]
19. Ipratropium bromide.
Gross NJ
N Engl J Med; 1988 Aug; 319(8):486-94. PubMed ID: 2970009
[No Abstract] [Full Text] [Related]
20. [Clinical use of atrovent].
Zamotaev IP; Maksimova LN
Klin Med (Mosk); 1984 Apr; 62(4):50-4. PubMed ID: 6234428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
